nelarabine
NDC 81927-111 · Shorla Oncology Inc.
Generic namenelarabine
Dosage formINJECTION
RouteINTRAVENOUS
Active ingredient(s)NELARABINE
Strength5 mg/mL
Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
Marketing categoryANDA
Packages
81927-111-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (81927-111-01) / 50 mL in 1 VIAL, SINGLE-DOSE
81927-111-06 — 6 VIAL, SINGLE-DOSE in 1 CARTON (81927-111-06) / 50 mL in 1 VIAL, SINGLE-DOSE
Billed under HCPCS
J9261 — Injection, nelarabine, 50 mg Medicare Part B payment limit (ASP + 6%): $65.41
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0078-0683 — nelarabine, 25021-259 — Nelarabine, 39822-0650 — Nelarabine, 43598-142 — Nelarabine, 46708-813 — nelarabine, 62332-813 — nelarabine, 66758-165 — nelarabine, 68083-233 — Nelarabine, 70121-1743 — Nelarabine, 70710-1726 — Nelarabine, 70710-1839 — Nelarabine, 70771-1685 — Nelarabine, 71288-165 — Nelarabine, 72205-154 — NELARABINE, 81927-375 — nelarabine